1.Effect of sildenafil citrate on interleukin-1beta-induced nitric oxide synthesis and iNOS expression in SW982 cells.
Kyung Ok KIM ; Shin Young PARK ; Chang Woo HAN ; Hyun Kee CHUNG ; Dae Hyun RYU ; Joong Soo HAN
Experimental & Molecular Medicine 2008;40(3):286-293
The purpose of this study was to identify the effect of sildenafil citrate on IL-1 beta induced nitric oxide (NO) synthesis and iNOS expression in human synovial sarcoma SW982 cells. IL-1 beta stimulated the cells to generate NO in both dose- and time-dependent manners. The IL-1 beta -induced NO synthesis was inhibited by guanylate cyclase (GC) inhibitor, LY83583. When the cells were treated with 8-bromo-cGMP, a hydrolyzable analog of cGMP, NO synthesis was increased upto 5-fold without IL-1 beta treatment suggesting that cGMP is an essential component for increasing the NO synthesis. Synoviocytes and chondrocytes contain strong cGMP phosphodiesterase (PDE) activity, which has biochemical features of PDE5. When SW982 cells were pretreated with sildenafil citrate (Viagra), a PDE5 specific inhibitor, sildenafil citrate significantly inhibited IL-1 beta -induced NO synthesis and iNOS expressions. From this result, we noticed that PDE5 activity is required for IL-1 beta -induced NO synthesis and iNOS expressions in human synovial sarcoma cells, and sildenafil citrate may be able to suppress an inflammatory reaction of synovium through inhibition of NO synthesis and iNOS expression by cytokines.
Anti-Inflammatory Agents/immunology/pharmacology
;
Cell Line, Tumor
;
Cyclic GMP/analogs & derivatives/immunology/metabolism
;
Cyclic Nucleotide Phosphodiesterases, Type 2/antagonists & inhibitors/metabolism
;
Humans
;
Interleukin-1beta/*metabolism
;
Male
;
Nitric Oxide/*biosynthesis/genetics/immunology
;
Nitric Oxide Synthase Type II/*biosynthesis/genetics/immunology
;
Phosphodiesterase Inhibitors/immunology/*pharmacology
;
Piperazines/immunology/*pharmacology
;
Purines/immunology/pharmacology
;
Signal Transduction/drug effects/genetics/immunology
;
Sulfones/immunology/*pharmacology
;
Synovial Membrane/enzymology/immunology
2.A novel beta-glucan produced by Paenibacillus polymyxa JB115 induces nitric oxide production in RAW264.7 macrophages.
Zhi Qiang CHANG ; Joong Su LEE ; Mi Hyun HWANG ; Joo Heon HONG ; Hee Kyoung JUNG ; Sam Pin LEE ; Seung Chun PARK
Journal of Veterinary Science 2009;10(2):165-167
The effect of extracellular beta-(1-->3), (1-->6)-glucan, produced by Paenibacillus polymyxa JB115, on nitric oxide (NO) production in RAW264.7 macrophages was investigated. beta-glucan induced the production of NO by RAW264.7 macrophages in a concentration- and time-dependent manner. Moreover, beta-glucan stimulation increased the mRNA expression of iNOS, COX-2 and IL-6 in RAW264.7 macrophages in a concentration-dependent manner.
Animals
;
Bacillus/*metabolism
;
Cell Line
;
Cyclooxygenase 2/biosynthesis/genetics
;
Interleukin-6/biosynthesis/genetics
;
Lipopolysaccharides/pharmacology
;
Macrophages/*drug effects/enzymology/immunology
;
Mice
;
Nitric Oxide/*biosynthesis/immunology
;
Nitric Oxide Synthase Type II/biosynthesis/genetics/metabolism
;
RNA, Messenger/biosynthesis/genetics
;
Reverse Transcriptase Polymerase Chain Reaction
;
beta-Glucans/metabolism/*pharmacology
3.Celastrol inhibits production of nitric oxideandproinflammatory cytokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells.
Hyo Won JUNG ; Yoo Sun CHUNG ; Yoon Seong KIM ; Yong Ki PARK
Experimental & Molecular Medicine 2007;39(6):715-721
Excessive production of nitric oxide (NO) and proinflammatory cytokines from activated microglia play an important role in human neurodegenerative disorders. Here, we investigated whether celastrol, which has been used as a potent anti-inflammatory and anti-oxidative agent in Chinese medicine, attenuates excessive production of NO and proinflammatory cytokines such as TNF-alpha and IL-1beta in LPS-stimulated BV-2 cells, a mouse microglial cell line. We report here that the LPS-elicited excessive production of NO, TNF-alpha, and IL-1beta in BV-2 cells was largely inhibited in the presence of celastrol, and the attenuation of inducible iNOS and these cytokines resulted from the reduced expression of mRNAs of iNOS and these cytokines, respectively. The molecular mechanisms that underlie celastrol-mediated attenuation were the inhibition of LPS-induced phosphorylation of MAPK/ERK1/2 and the DNA binding activity of NF-kappaB in BV-2 cells. The results indicate that celastrol effectively attenuated NO and proinflammatory cytokine production via the inhibition of ERK1/2 phosphorylation and NF-kappaB activation in LPS-activated microglia. Thus, celastrol may be an effective therapeutic candidate for use in the treatment of neurodegenerative human brain disorders.
Animals
;
Cell Line
;
Cytokines/*biosynthesis/drug effects
;
Gene Expression Regulation, Enzymologic/drug effects/immunology
;
Inflammation/immunology
;
Inflammation Mediators/immunology
;
Mice
;
Microglia/*drug effects/immunology
;
Mitogen-Activated Protein Kinases/*physiology
;
NF-kappa B/metabolism/*physiology
;
Nitric Oxide/*metabolism
;
Nitric Oxide Synthase Type II/biosynthesis/drug effects
;
RNA, Messenger/analysis
;
Signal Transduction/*drug effects/physiology
;
Transcription, Genetic/drug effects/immunology
;
Triterpenes/*pharmacology
4.The polysaccharide isolated from Pleurotus nebrodensis (PN-S) shows immune-stimulating activity in RAW264.7 macrophages.
Hai-Yan CUI ; Chang-Lu WANG ; Yu-Rong WANG ; Zhen-Jing LI ; Ya-Nan ZHANG
Chinese Journal of Natural Medicines (English Ed.) 2015;13(5):355-360
A novel Pleurotus nebrodensis polysaccharide (PN-S) was purified and characterized, and its immune-stimulating activity was evaluated in RAW264.7 macrophages. PN-S induced the proliferation of RAW264.7 cells in a dose-dependent manner, as determined by the MTT assay. After exposure to PN-S, the phagocytosis of the macrophages was significantly improved, with remarkable changes in morphology being observed. Flow cytometric analysis demonstrated that PN-S promoted RAW264.7 cells to progress through S and G2/M phases. PN-S treatment enhanced the productions of interleukin-6 (IL-6), nitric oxide (NO), interferon gamma (INF-γ), and tumor necrosis factor-α (TNF-α) in the macrophages, with up-regulation of mRNA expressions of interleukin-6 (IL-6), inducible nitric oxide synthase (iNOS), interferon gamma(INF-γ) and tumor necrosis factor-α (TNF-α) being observed in a dose-dependent manner, as measured by qRT-PCR. In conclusion, these results suggest that the purified PN-S can improve immunity by activating macrophages.
Animals
;
Cell Cycle
;
immunology
;
Cell Line
;
Cell Proliferation
;
drug effects
;
Fungal Polysaccharides
;
pharmacology
;
Immunity
;
drug effects
;
Interferon-gamma
;
biosynthesis
;
metabolism
;
Interleukin-6
;
biosynthesis
;
metabolism
;
Macrophages
;
immunology
;
metabolism
;
Mice
;
Nitric Oxide
;
biosynthesis
;
Nitric Oxide Synthase Type II
;
metabolism
;
Pleurotus
;
RNA, Messenger
;
metabolism
;
Reverse Transcriptase Polymerase Chain Reaction
;
Tumor Necrosis Factor-alpha
;
biosynthesis
;
metabolism
;
Up-Regulation
5.Phagocytosis of serum-and IgG-opsonized zymos an particles induces apoptosis through superoxide but not nitric oxide in macrophage J774A.1.
Jun Sub KIM ; Hyeok Yil KWON ; Won Ho CHOI ; Chan Young JEON ; Jong Il KIM ; Jaebong KIM ; Jae Yong LEE ; Yong Sun KIM ; Jae Bong PARK
Experimental & Molecular Medicine 2003;35(3):211-221
Phagocytosis of serum- and IgG-opsonized zymosan (SOZ and IOZ, respectively) particles into J774A.1 macrophages induced apoptosis of the cells, accompanied by the expression of p21(WAF1), one of cyclin-dependent protein kinase (CDK) inhibitors. Furthermore, phagocytosis of SOZ and IOZ particles into macophages induced superoxide formation. Tat-superoxide dismutase (SOD), which is readily transduced into the cells using Tat-domain, protected the cells from the apoptosis induced by phagocytosis of SOZ and IOZ particles. lipopolysaccharide (LPS)/interferon-gamma (IFN-gamma) also caused the apoptosis of the cells. However, Tat-SOD could not protect the cells from LPS/IFN-gamma induced apoptosis, suggesting that apoptosis mechanisms involved are different from each other. In the present study, we determined the amounts of nitric oxide (NO) produced by SOZ, IOZ, and LPS/IFN-gamma, and found that SOZ and IOZ did not induce the generation of NO in macrophages, whereas LPS/ IFN-gamma did. The apoptosis due to phagocytosis was accompanied with the release of cytochrome c from mitochondrial membrane to cytosolic fraction. Furthermore, SOZ and IOZ induced the cleavage of procasapase-3 (35 kDa) to give rise to an active caspase-3 (20 kDa), which was blocked by Tat- SOD but not by 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide (PTIO), a scavenger of NO. On the other hand, LPS/IFN-gamma caused the activation of procaspase-3, which was blocked by PTIO but not by Tat-SOD. Taken together, phagocytosis of SOZ and IOZ particles induced apoptosis through superoxide but not NO in macrophages, accompanied with the release of cytochrome c and the activation of caspase-3.
Apoptosis/*immunology
;
Caspases/metabolism
;
Cell Line
;
Cyclins/biosynthesis
;
Cytochromes c/metabolism
;
Immunoglobulin G/*immunology
;
Interferon Type II/pharmacology
;
Lipopolysaccharides/pharmacology
;
Macrophages/*immunology/metabolism
;
Nitric Oxide/*metabolism
;
Opsonins/immunology
;
Phagocytosis/*physiology
;
Superoxide Dismutase/metabolism
;
Superoxides/*metabolism
;
Zymosan
6.The role of different subtypes of G protein in the secretory function of macrophages stimulated by activated complement following severe burn injury.
Yuan-bing HU ; Dai-zhi PENG ; Wen-hua HUANG ; Ao LI ; Xin ZHOU
Chinese Journal of Burns 2005;21(6):410-413
OBJECTIVETo investigate the influence of activated complement on the secretory function of peritoneal macrophage (PMphi) in the production of nitric oxide (NO) and tumor necrosis factor-alpha (TNF-alpha), especially in the role of different G-protein subtypes in this process after burns.
METHODSThe mice inflicted by 18% TBSA full-thickness scald was established and employed as the model. And the mice were divided into A (the complements were preserved and activated) and B (with intraperitoneal injection of CVF to deplete complement before scald) groups. The plasma of the mice in the two groups was collected at 6 postburn hour (PBH) and cultured with PMphi from normal mice. The PMphi were pretreated with pertussis toxin (PT) and with cholera toxin (CT). The NO and TNF-alpha levels in the supernatant of normal PMphi culture with different pretreatment were measured by Greiss assay.
RESULTSThe NO and TNF-alpha contents in group A [(80 +/- 12) micromol/L, (46 +/- 6)%] were obviously higher than those in group B [(34 +/- 5) micromol/L, (26 +/- 5)%, P < 0.01]. The NO content produced by PMphi (45 +/- 10 micromol/L) in A group decreased (P < 0.01), while the TNF-alpha activity (58 +/- 10)% increased by PT pretreatment (P < 0.05). On the contrary, the NO content produced by PMphi (105 +/- 18 micromol/L) in group A increased (P < 0.01), while the TNF-alpha activity (27 +/- 6)% decreased by CT pretreatment (P < 0.01).
CONCLUSIONThese results indicates that the secretory function of normal PMphi can be enhanced by complement activation after thermal injury, which might partly be due to the effect of activated complement components through complement receptor coupled G-protein. In the secretory function of complement stimulated Mphi, Gi protein has a major role in the production of NO, Gs protein is mainly involved in the secretion of TNF-alpha.
Animals ; Burns ; immunology ; metabolism ; Complement Activation ; Complement System Proteins ; metabolism ; Female ; GTP-Binding Proteins ; metabolism ; Macrophage Activation ; immunology ; Macrophages, Peritoneal ; secretion ; Male ; Mice ; Mice, Inbred Strains ; Nitric Oxide ; biosynthesis ; Signal Transduction ; Tumor Necrosis Factor-alpha ; biosynthesis
7.Effects of iNOS inhibitor on IFN-gamma production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii.
Ki Man KANG ; Gye Sung LEE ; Jae Ho LEE ; In Wook CHOI ; Dae Whan SHIN ; Young Ha LEE
The Korean Journal of Parasitology 2004;42(4):175-183
To evaluate the role of nitric oxide (NO) in IFN-gamma production and apoptosis of splenocytes in genetically different strains of mice with toxoplasmosis, BALB/c (a toxoplasmosis resistant strain) and C57BL/6 (a toxoplasmosis susceptible strain) mice were infected with Toxoplasma gondii cysts orally and subsequently injected intraperitoneally with aminoguanidine, an iNOS inhibitor (AG; 35 mg/kg per mouse daily for 14 days). When BALB/c or C57BL/6 mice were infected with T. gondii without AG treatment, number of brain cysts, NO and IFN-gamma production by splenocytes, and percentages of apoptotic splenocytes were increased compared to uninfected control mice without AG treatment. AG treatment increased the number of brain cysts, and reduced NO and IFN-gamma production in T. gondii-infected C57BL/6 mice. In contrast, in T. gondii-infected BABL/c mice, the number of brain cysts, and NO and IFN-gamma production of splenocytes was not altered by treatment with AG. However, the percentages of apoptotic splenocytes in T. gondii-infected BALB/c or C57BL/6 mice were not affected by AG treatment. These results suggest that NO modulates IFN-gamma production in T. gondii-infected C57BL/6 mice, and that NO is involved in mediating a protective response in toxoplasmosis susceptible, but not resistant, mice strain during acute infection.
Animals
;
Apoptosis/drug effects/*immunology
;
Comparative Study
;
Female
;
Guanidines/*pharmacology
;
Interferon Type II/*biosynthesis
;
Mice
;
Mice, Inbred BALB C
;
Mice, Inbred C57BL
;
Nitric Oxide/*biosynthesis
;
Nitric-Oxide Synthase/*antagonists & inhibitors
;
Research Support, Non-U.S. Gov't
;
Species Specificity
;
Spleen/immunology
;
Toxoplasmosis, Animal/*immunology
8.Construction of recombinant Mycobacterium smegmatis expressing ESAT-6 and its effects on macrophages.
Yan LI ; Lang BAO ; Hui-dong ZHANG ; Ya-sha LI ; Hai-long ZHU
Journal of Southern Medical University 2006;26(7):923-926
OBJECTIVEObjective To construct recombinant Mycobacterium smegmatis expressing ESAT-6 of the human pathogen Mycobacterium tuberculosis.
METHODSESAT-6 gene was amplified from M. tuberculosis genomic DNA and inserted into an E.coli-mycobacterium shuttle vector under the control of HSP60 promoter. The recombinant vector was transformed into M. smegmatis by electroporation. To assess the ability of recombinant M. smegmatis to activate macrophage, mouse macrophage ANA-1 was cocultured with recombinant M. smegmatis. The apoptosis of ANA-1 cells was detected by flow cytometry and iNOS mRNA expression of the cells was detected by reverse transcription-polymerase chain reaction (RT-PCR). The survival of M. smegmatis strains in ANA-1 cells was evaluated.
RESULTSThe recombinant vector was verified by restriction endonuclease digestion and DNA sequencing. ESAT-6 protein was expressed in M. smegmatis in response to heat shock and the molecular weight of the expression product was identical to the expected value. The growth curve of the new recombinant M. smegmatis was consistent with that of the wild-type strain, suggesting the absence of ESAT-6 protein toxicity against M. smegmatis. The recombinant M. smegmatis did not induce significant changes in mouse macrophage ANA-1 apoptosis. Coculture of the macrophages with recombinant M. smegmatis for 4 to 24 h could induce iNOS expression in the former, and the CFU of recombination M. smegmatis grown in ANA-1 cells was much less than that of the control bacteria.
CONCLUSIONThe recombinant M. smegmatis expressing M. tuberculosis ESAT-6 gene possess immunogenicity, which provides experimental evidence for the development of novel M. smegmatis-based vaccine against tuberculosis.
Animals ; Antigens, Bacterial ; biosynthesis ; genetics ; immunology ; Apoptosis ; immunology ; Bacterial Proteins ; biosynthesis ; genetics ; immunology ; Cell Line ; Electrophoresis, Polyacrylamide Gel ; Escherichia coli ; genetics ; Flow Cytometry ; Genetic Vectors ; Humans ; Macrophage Activation ; immunology ; Macrophages ; cytology ; immunology ; metabolism ; Mice ; Mycobacterium smegmatis ; genetics ; metabolism ; Nitric Oxide Synthase Type II ; genetics ; RNA, Messenger ; genetics ; metabolism ; Recombinant Proteins ; biosynthesis ; genetics ; immunology ; Reverse Transcriptase Polymerase Chain Reaction ; Transformation, Genetic
9.Radiation-induced bystander effect in immune response.
Shu-Zheng LIU ; Shun-Zi JIN ; Xiao-Dong LIU
Biomedical and Environmental Sciences 2004;17(1):40-46
OBJECTIVESince most reports on bystander effect have been only concerned with radiation-induced damage, the present paper aimed at disclosing whether low dose radiation could induce a stimulatory or beneficial bystander effect.
METHODSA co-culture system containing irradiated antigen presenting cells (J774A.1) and unirradiated T lymphocytes (EL-4) was established to observe the effect of J774A.1 cells exposed to both low and high doses of X-rays on the unirradiated EL-4 cells. Incorporation of 3H-TdR was used to assess the proliferation of the EL-4 cells, expression of CD80/86 and CD48 on J774A.1 cells was measured with immunohistochemistry and flow cytometry, respectively. NO release from J774A.1 cells was estimated with nitrate reduction method.
RESULTSLow dose-irradiated J774A.1 cells could stimulate the proliferation of the unirradiated EL-4 cells while the high dose-irradiated J774A.1 cells exerted an inhibitory effect on the proliferation of the unirradiated EL-4 cells. Preliminary mechanistic studies illustrated that the differential changes in CD48 expression and NO production by the irradiated J774A.1 cells after high and low dose radiation might be important factors underlying the differential bystander effect elicited by different doses of radiation.
CONCLUSIONStimulatory bystander effect can be induced in immune cells by low dose radiation.
Animals ; Antigen-Presenting Cells ; immunology ; metabolism ; radiation effects ; Antigens, CD ; immunology ; B7-1 Antigen ; immunology ; B7-2 Antigen ; Bystander Effect ; radiation effects ; Cell Division ; immunology ; Cell Line ; Coculture Techniques ; Dose-Response Relationship, Radiation ; Membrane Glycoproteins ; immunology ; Mice ; Nitric Oxide ; biosynthesis ; T-Lymphocytes ; immunology ; X-Rays
10.Colchicine-derived compound CT20126 promotes skin allograft survival by regulating the balance of Th1 and Th2 cytokine production.
Seon Jin LEE ; Seung NAMKOONG ; Kwon Soo HA ; Woo Dong NAM ; Young Guen KWON ; Hansoo LEE ; Eun Young YOON ; Dong Jo CHANG ; Soon Ok KIM ; Young Myeong KIM
Experimental & Molecular Medicine 2007;39(2):230-238
Colchicine has been shown to regulate the expression of inflammatory gene, but this compound possesses much weaker anti-inflammatory activity. In this study, we synthesized a new colchicine derivative CT20126 and examined its immunomodulatory property. CT20126 was found to have immunosuppressive effects by inhibiting lymphocyte proliferation without cytotoxicity and effectively inhibit the transcriptional expression of the inflammatory genes, iNOS, TNF-alpha, and IL-1beta, in macrophages stimulated by LPS. This effect was nearly comparable to that of cyclosporine A. This compound also significantly suppressed the production of nitric oxide and Th1-related pro-inflammatory cytokines, IL-1beta, TNF-alpha, and IL-2, with minimal suppression of Th2-related anti-inflammatory cytokines IL-4 and IL-10 in the sponge matrix allograft model. Moreover, administration of CT20126 prolonged the survival of allograft skins from BALB/c mice (H-2d) to the dorsum of C57BL/6 (H-2b) mice. The in vivo immune suppressive effects of CT20126 were similar to that of cyclosporine A. These results indicate that this compound may have potential therapeutic value for transplantation rejection and other inflammatory diseases.
Animals
;
Cell Line
;
Colchicine/*analogs & derivatives/chemistry/*pharmacology
;
Cytokines/*biosynthesis
;
Female
;
Gene Expression Regulation/drug effects
;
Graft Survival/*drug effects
;
Immunosuppression
;
Interleukin-1beta/genetics/metabolism
;
Lipopolysaccharides/pharmacology
;
Lymphocyte Culture Test, Mixed
;
Mice
;
Mice, Inbred BALB C
;
Mice, Inbred C57BL
;
Nitric Oxide/biosynthesis
;
Nitric Oxide Synthase Type II/genetics/metabolism
;
Skin Transplantation/*immunology
;
Th1 Cells/*drug effects/immunology/metabolism
;
Th2 Cells/*drug effects/immunology/metabolism
;
Transplantation, Homologous
;
Tumor Necrosis Factor-alpha/genetics/metabolism